Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

28Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess whether the sequence in which anthracyclines and taxanes are administered, in an adjuvant or neoadjuvant setting, affects outcomes in women with early breast cancer.

Cite

CITATION STYLE

APA

Zaheed, M., Wilcken, N., Willson, M. L., O’Connell, D. L., & Goodwin, A. (2017). Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. Cochrane Database of Systematic Reviews, 2017(11). https://doi.org/10.1002/14651858.CD012873

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free